VetStem, Inc. is a leading company in regenerative veterinary medicine, aiming to improve the lives of animals through the use of regenerative stem cells. Established in 2002, VetStem is the first company in the United States to offer adipose-derived stem cell services to veterinarians for their patients. With over 50 patents and world-wide veterinary rights for the use of adipose-derived stem cells, VetStem is at the forefront of innovation in the Biopharma, Health Care, and Pharmaceutical industries. The company has achieved significant success, treating over 4,000 horses with their own healing stem cells for tendon injuries and witnessing a high return to performance rate. Additionally, VetStem has made groundbreaking progress in treating dogs with osteoarthritis and orthopedic soft tissue injuries, with over 3,000 dogs and cats undergoing their stem cell therapy by 2011.
Looking to the future, VetStem is actively researching stem cell therapy for immune-mediated and inflammatory diseases, as well as organ disease and failure. Collaborating with human medicine partners, the company aspires to contribute to advances in human medical treatment. VetStem's work promises a significantly improved quality of life for both animals and their owners.